A paradigm shift in cancer research based on integrative multi-omics approaches: glutaminase serves as a pioneering cuproptosis-related gene in pan-cancer
Abstract Background Cuproptosis is a newly identified form of unprogrammed cell death. As a pivotal metabolic regulator, glutaminase (GLS) has recently been discovered to be linked to cuproptosis. Despite this discovery, the oncogenic functions and mechanisms of GLS in various cancers are still not...
Main Authors: | Hai-hong Shi, Joseph Mugaanyi, Changjiang Lu, Yang Li, Jing Huang, Lei Dai |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-04-01
|
Series: | BMC Women's Health |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12905-024-03061-8 |
Similar Items
-
Bioinformatic profiling identifies the glutaminase to be a potential novel cuproptosis-related biomarker for glioma
by: Zhen Ouyang, et al.
Published: (2022-09-01) -
Pan-cancer patterns of cuproptosis markers reveal biologically and clinically relevant cancer subtypes
by: Fanqin Bu, et al.
Published: (2023-01-01) -
Identification of a novel cuproptosis-associated lncRNA model that can improve prognosis prediction in uterine corpus endometrial carcinoma
by: Bohan Li, et al.
Published: (2023-12-01) -
Regulation, genomics, and clinical characteristics of cuproptosis regulators in pan-cancer
by: Cankun Zhou, et al.
Published: (2022-10-01) -
Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma
by: Yun Chen
Published: (2022-07-01)